Movement Alert|PHARMARON Intraday Rise 3.29%, JPMorgan Chase Increases Stake to 15.31%

Market Focus
Yesterday

On October 6, PHARMARON rose 3.29% in regular trading, trading at HK$32.66/share, with turnover of HK$22.28 million.

This follows JPMorgan Chase & Co.’s acquisition of 3.18 million shares at approximately HK$30.33 per share on September 29, raising their beneficial ownership from 14.43% to 15.31%. Such institutional stake-building often signals confidence in the company’s growth prospects, particularly after PHARMARON reported 17.9% year-over-year revenue growth for the first half of 2026.

The Life Sciences Tools & Services sector showed mixed movement today: WUXI BIO up 4.33%, GENSCRIPT BIO up 5.57%, WUXI APPTEC up 1.51%, XTALPI up 4.46%, INSILICO up 4.56%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10